首页>
外国专利>
Concurrent Chemotherapy and Immunotherapy
Concurrent Chemotherapy and Immunotherapy
展开▼
机译:并行化学疗法和免疫疗法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The concurrent administration of chemotherapy and immunotherapy has been considered a contraindication because of the concern that the induced lymphopenia would ablate therapeutic efficacy of immunotherapy. Temozolomide has been shown to be an effective chemotherapeutic for patients with malignant gliomas and to deprive patients with glioblastoma (GBM) patients of this agent in order to treat with immunotherapy is controversial. Despite conventional dogma, we demonstrate that both chemotherapy and immunotherapy can be delivered concurrently without negating the effects of immunotherapy. In fact, the temozolomide induced lymphopenia may actually be synergistic with a peptide vaccine.
展开▼